
Governance
Corporate Governance Structure
With our vision as pioneers from Japan to lead the new era of biopharma and medicine, innovating for both Japanese patients and the world, we recognize that building an effective system of corporate governance is an important management priority to enhance corporate value over the medium to long term.
We continue to strengthen our governance structure and management system through the appointment of independent external directors of cooperation among the Audit Committee, the external auditor and the Internal Audit Department to support the strategic management and oversight functions of our Board of Directors.
At the same time, we strive to increase the integrity and transparency of our management governance structure by maintaining accountability to and communication with all stakeholders, including shareholders, employees, business partners, customers, creditors, consumers and local communities.
We employ a governance structure comprising the Nomination Committee, Audit Committee and Compensation Committee as stipulated by the Companies Act of Japan in order to strengthen our Board of Directors’ oversight, increase transparency and speed up the decision-making of management, among other reasons. Under this structure, we have separated the oversight function and business execution function of management and have largely delegated business decision-making authorities to our Executive Officers and Executive Vice Presidents ("EVPs") to increase management oversight and efficiencies. Our key principles are set out in our Corporate Governance Guidelines.
Board of Directors and Executive Officers
Independent External Directors
Nomination Committee
Compensation Committee
Audit Committee
Investment Committee
Scientific Advisory Board